Atrial fibrillation and Ventricular Tachyarrhythmias: Advancements for better outcomes

Gheini, Alireza and Pourya, Afsoun and Pooria, Ali (2020) Atrial fibrillation and Ventricular Tachyarrhythmias: Advancements for better outcomes. Cardiovasc Hematol Disord Drug Targets.

Full text not available from this repository.


Cardiac arrhythmias are associated with several cardiac diseases and are prevalent in people with or without structural and valvular abnormalities. Ventricular arrhythmias (VA) can be life threating and its onset requires immediate medical attention. Similarly, atrial fibrillation and flutter lead to stroke, heart failure and even death. Optimal treatment of VA is very variable and depends on the medical condition associated with the rhythm disorder (which includes reversible causes such as myocardial ischemia or pro-arrhythmic drugs). While an implanted cardioverter defibrillator is often indicated in secondary prevention of VA. This review highlights newest advancements in these techniques and management of ventricular and atrial tachyarrhythmias, along with pharmacological therapy. Keywords: Atrial tachyarrhythmias; Cardiac arrhythmias; Heart failure; Valvular abnormalities; Ventricular arrhythmias (VA); myocardial ischemia..

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: samira sepahvandy
Date Deposited: 07 Oct 2020 04:29
Last Modified: 07 Oct 2020 04:29

Actions (login required)

View Item View Item